Glioma targeted therapy: insight into future of molecular approaches

K Yang, Z Wu, H Zhang, N Zhang, W Wu, Z Wang… - Molecular Cancer, 2022 - Springer
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically,
gliomas occur among all ages, more often seen in adults, which males are more susceptible …

Targeting TGFβ signal transduction for cancer therapy

S Liu, J Ren, P Ten Dijke - Signal transduction and targeted therapy, 2021 - nature.com
Transforming growth factor-β (TGFβ) family members are structurally and functionally related
cytokines that have diverse effects on the regulation of cell fate during embryonic …

Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge

M Nedeljković, A Damjanović - Cells, 2019 - mdpi.com
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …

Brain immunology and immunotherapy in brain tumours

JH Sampson, MD Gunn, PE Fecci, DM Ashley - Nature Reviews Cancer, 2020 - nature.com
Gliomas, the most common malignant primary brain tumours, remain universally lethal. Yet,
seminal discoveries in the past 5 years have clarified the anatomy, genetics and function of …

Molecular targeted therapy of glioblastoma

E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer treatment …, 2019 - Elsevier
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …

Next generation of immune checkpoint therapy in cancer: new developments and challenges

JA Marin-Acevedo, B Dholaria, AE Soyano… - Journal of hematology & …, 2018 - Springer
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …

[PDF][PDF] Targeting cancer stemness in the clinic: from hype to hope

C Saygin, D Matei, R Majeti, O Reizes, JD Lathia - Cell stem cell, 2019 - cell.com
Tumors are composed of non-homogeneous cell populations exhibiting varying degrees of
genetic and functional heterogeneity. Cancer stem cells (CSCs) are capable of sustaining …

Targeting TGF-β signaling in cancer

S Colak, P Ten Dijke - Trends in cancer, 2017 - cell.com
The transforming growth factor (TGF)-β signaling pathway is deregulated in many diseases,
including cancer. In healthy cells and early-stage cancer cells, this pathway has tumor …

[HTML][HTML] Clinical development of therapies targeting TGFβ: current knowledge and future perspectives

D Ciardiello, E Elez, J Tabernero, J Seoane - Annals of Oncology, 2020 - Elsevier
Transforming growth factor beta (TGFβ) is a pleiotropic cytokine that plays a key role in both
physiologic and pathologic conditions, including cancer. Importantly, TGFβ can exhibit both …

Molecular mechanisms of treatment resistance in glioblastoma

A Ou, WKA Yung, N Majd - International journal of molecular sciences, 2020 - mdpi.com
Glioblastoma is the most common malignant primary brain tumor in adults and is almost
invariably fatal. Despite our growing understanding of the various mechanisms underlying …